Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR

Abstract Background Breast cancer (BC) is the most common malignant disease in female patients worldwide. In HER-2+ BC patients, trastuzumab therapy is associated with a better prognosis. However, many HER-2+ BC patients experience recurrence or metastasis because of trastuzumab resistance. The mech...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Cuiwei Liu, Chong Lu, Lamu Yixi, Jiaxing Hong, Fang Dong, Shengnan Ruan, Ting Hu, Xiangwang Zhao
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2023-10-01
Sarja:	Breast Cancer Research
Aiheet:	Exosomes Linc00969 Breast cancer HER-2 HUR
Linkit:	https://doi.org/10.1186/s13058-023-01720-6
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!